Denali Therapeutics shares owned by ProFund Advisors
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by ProFund Advisors
from 13F filings
Historical chart of ProFund Advisors investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by ProFund Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $828k | 40k | 20.63 |
| 2023-06-30 | $1.4M | 47k | 29.51 |
| 2023-03-31 | $1.1M | 49k | 23.04 |
| 2022-12-31 | $414k | 15k | 27.81 |
| 2022-09-30 | $398k | 13k | 30.71 |
| 2022-06-30 | $376k | 13k | 29.43 |
| 2022-03-31 | $459k | 14k | 32.20 |
| 2021-12-31 | $706k | 16k | 44.57 |
| 2021-09-30 | $891k | 18k | 50.47 |
| 2021-06-30 | $210k | 2.7k | 78.62 |